Cancelight - Re-defining Cancer Treatment

Million

PREDICTED NEW CASES OF CANCER DIAGNOSES IN 2025 WORLDWIDE

Statista, 2025

Million

PREDICTED CANCER DEATHS WORLDWIDE IN 2025

Statista, 2025

Percent

CANCER RELATED DEATHS ATTRIBUTED TO DRUG RESISTANCE

(Cancer.gov; Phillips, 2024)

We want to change that by combining cutting-edge microscopy with personalized AI

🔬

BRINGING LIGHT TO DARKNESS

Real-time, label-free imaging of 3-D tissue & cells with spatial resolution

🧠

AI EXTRACTING INSIGHTS

Personalized AI-driven prediction models for tissue characterization & drug response

THE FUTURE OF CANCER DIAGNOSTICS

Cost-effective, scalable, multiplexable

BIOMARKERS

91% confidence

CLASS

TYPE II

Malignant

BRINGING LIGHT TO DARKNESS

Real-time, label-free imaging of 3-D tissue & cells

AI EXTRACTING INSIGHTS

AI-driven prediction models for tissue analysis

BIOMARKERS

97% confidence

CLASS

TYPE IV

94% confidence

THE FUTURE OF CANCER DIAGNOSTICS

Cost-effective, scalable, multiplexable

Our Team

Dr. Katharina Sahiri

Founder & CEO

Dr. Miguel Guirao Ortiz

Founder & CMO

Michael Isselstein

Founder & CTO

Sofia Fuentes

Founder's Associate

Dr. Raven Bunk

AI Architect

PREDICTED NEW CASES OF CANCER DIAGNOSES IN 2025 WORLDWIDE

PREDICTED CANCER DEATHS WORLDWIDE IN 2025

CANCER RELATED DEATHS ATTRIBUTED TO DRUG RESISTANCE

We want to change that by combining cutting-edge microscopy with personalized AI

BRINGING LIGHT TO DARKNESS

AI EXTRACTING INSIGHTS

THE FUTURE OF CANCER DIAGNOSTICS

BRINGING LIGHT TO DARKNESS

AI EXTRACTING INSIGHTS

THE FUTURE OF CANCER DIAGNOSTICS

Our Team

Dr. Katharina Sahiri

Dr. Miguel Guirao Ortiz

Michael Isselstein

Sofia Fuentes

Dr. Raven Bunk

Supported by